← Back to IMDX

Insight Molecular Diagnostics Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 10/08/2026Mar 2026Filed 13/05/2026Sep 2025Filed 10/11/2025Jun 2025Filed 10/08/2026Mar 2025Filed 13/05/2026Sep 2024Filed 10/11/2025Jun 2024Filed 11/08/2025Mar 2024Filed 12/05/2025
$0.2$0$0.3$0.5$2.1$0.1$0.1$0.2
−$11−$4.3−$11−$9.7−$6.7−$13−$4.5−$9.1
−$0.31−$0.12−$0.34−$0.30−$0.26−$0.98−$0.36−$1.13
373532322614138.3

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.